vs
Side-by-side financial comparison of Noble Corp plc (NE) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Noble Corp plc is the larger business by last-quarter revenue ($764.4M vs $622.0M, roughly 1.2× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 11.3%, a 23.1% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -17.6%). Over the past eight quarters, Noble Corp plc's revenue compounded faster (9.5% CAGR vs 4.6%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
NE vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $764.4M | $622.0M |
| Net Profit | $86.6M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 5.6% | 62.4% |
| Net Margin | 11.3% | 34.4% |
| Revenue YoY | -17.6% | 4.8% |
| Net Profit YoY | -10.4% | 2.9% |
| EPS (diluted) | $0.54 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $764.4M | $622.0M | ||
| Q3 25 | $798.0M | $609.3M | ||
| Q2 25 | $848.7M | $578.7M | ||
| Q1 25 | $874.5M | $568.2M | ||
| Q4 24 | $927.3M | $593.6M | ||
| Q3 24 | $800.5M | $564.7M | ||
| Q2 24 | $692.8M | $537.3M | ||
| Q1 24 | $637.1M | $568.0M |
| Q4 25 | $86.6M | $214.2M | ||
| Q3 25 | $-21.1M | $288.2M | ||
| Q2 25 | $42.9M | $30.2M | ||
| Q1 25 | $108.3M | $238.3M | ||
| Q4 24 | $96.6M | $208.2M | ||
| Q3 24 | $61.2M | $544.0M | ||
| Q2 24 | $195.0M | $102.0M | ||
| Q1 24 | $95.5M | $4.8M |
| Q4 25 | 5.6% | 62.4% | ||
| Q3 25 | 6.3% | 70.1% | ||
| Q2 25 | 15.9% | 36.3% | ||
| Q1 25 | 21.4% | 94.0% | ||
| Q4 24 | 18.4% | 60.9% | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 30.3% | 50.2% | ||
| Q1 24 | 16.9% | -13.0% |
| Q4 25 | 11.3% | 34.4% | ||
| Q3 25 | -2.6% | 47.3% | ||
| Q2 25 | 5.1% | 5.2% | ||
| Q1 25 | 12.4% | 41.9% | ||
| Q4 24 | 10.4% | 35.1% | ||
| Q3 24 | 7.6% | 96.3% | ||
| Q2 24 | 28.1% | 19.0% | ||
| Q1 24 | 15.0% | 0.8% |
| Q4 25 | $0.54 | $0.49 | ||
| Q3 25 | $-0.13 | $0.67 | ||
| Q2 25 | $0.27 | $0.07 | ||
| Q1 25 | $0.67 | $0.55 | ||
| Q4 24 | $0.56 | $0.46 | ||
| Q3 24 | $0.40 | $1.21 | ||
| Q2 24 | $1.34 | $0.23 | ||
| Q1 24 | $0.66 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $471.4M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $4.5B | $9.7B |
| Total Assets | $7.5B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $471.4M | $618.7M | ||
| Q3 25 | $477.9M | $938.9M | ||
| Q2 25 | $338.2M | $631.9M | ||
| Q1 25 | $303.8M | $1.1B | ||
| Q4 24 | $247.3M | $929.0M | ||
| Q3 24 | $391.9M | $950.1M | ||
| Q2 24 | $162.9M | $1.8B | ||
| Q1 24 | $212.5M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $4.5B | $9.7B | ||
| Q3 25 | $4.5B | $9.6B | ||
| Q2 25 | $4.6B | $9.5B | ||
| Q1 25 | $4.7B | $9.8B | ||
| Q4 24 | $4.7B | $10.3B | ||
| Q3 24 | $4.7B | $10.3B | ||
| Q2 24 | $4.0B | $9.8B | ||
| Q1 24 | $3.9B | $9.9B |
| Q4 25 | $7.5B | $19.6B | ||
| Q3 25 | $7.6B | $19.3B | ||
| Q2 25 | $7.7B | $18.3B | ||
| Q1 25 | $7.9B | $17.6B | ||
| Q4 24 | $8.0B | $18.2B | ||
| Q3 24 | $8.0B | $18.0B | ||
| Q2 24 | $5.6B | $17.7B | ||
| Q1 24 | $5.4B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $187.1M | $827.1M |
| Free Cash FlowOCF − Capex | $35.4M | — |
| FCF MarginFCF / Revenue | 4.6% | — |
| Capex IntensityCapex / Revenue | 19.9% | — |
| Cash ConversionOCF / Net Profit | 2.16× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $432.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.1M | $827.1M | ||
| Q3 25 | $277.1M | $702.6M | ||
| Q2 25 | $216.4M | $364.0M | ||
| Q1 25 | $271.1M | $596.1M | ||
| Q4 24 | $136.2M | $742.5M | ||
| Q3 24 | $283.8M | $703.6M | ||
| Q2 24 | $106.8M | $658.2M | ||
| Q1 24 | $128.7M | $664.6M |
| Q4 25 | $35.4M | — | ||
| Q3 25 | $139.5M | — | ||
| Q2 25 | $99.8M | — | ||
| Q1 25 | $157.5M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $156.8M | — | ||
| Q2 24 | $-34.3M | — | ||
| Q1 24 | $-37.9M | — |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 11.8% | — | ||
| Q1 25 | 18.0% | — | ||
| Q4 24 | -0.5% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | -4.9% | — | ||
| Q1 24 | -6.0% | — |
| Q4 25 | 19.9% | — | ||
| Q3 25 | 17.3% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 13.0% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 15.9% | — | ||
| Q2 24 | 20.4% | — | ||
| Q1 24 | 26.2% | — |
| Q4 25 | 2.16× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 5.05× | 12.06× | ||
| Q1 25 | 2.50× | 2.50× | ||
| Q4 24 | 1.41× | 3.57× | ||
| Q3 24 | 4.64× | 1.29× | ||
| Q2 24 | 0.55× | 6.45× | ||
| Q1 24 | 1.35× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
